SCHEMBL6599608

SCHEMBL6599608

Fc1ccc(-c2nc(Sc3ccccc3)[nH]c2-c2ccncc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 16/20 0.70
MAPK13 O15264 8/20 0.69
MAPK12 P53778 8/20 0.69
MAPK11 Q15759 8/20 0.69
GCGR P47871 6/20 0.65
ALOX5 P09917 5/20 0.65
CSNK1D P48730 4/20 0.59
PRKD3 O94806 2/20 0.59
MAP4K4 O95819 2/20 0.59
FRK P42685 2/20 0.59
MAPK9 P45984 2/20 0.59
CSNK1A1 P48729 2/20 0.59
GSK3B P49841 2/20 0.59
PRKD2 Q9BZL6 2/20 0.59
CLK4 Q9HAZ1 2/20 0.59
PTK6 Q13882 1/20 0.59
BRAF P15056 1/20 0.58
CSNK1E P49674 2/20 0.57
LCK P06239 1/20 0.56
RET P07949 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11469982 0.82 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4467677 0.82 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13712659 0.82 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4460547 0.82 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4464755 0.81 MAPK14 (0.80) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4091788 0.79 MAPK14 (0.65) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4552316 0.79 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL9195042 0.79 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4459150 0.78 MAPK14 (0.76) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL11502760 0.78 MAPK14 (0.73) MAPK14MAPK13MAPK12MAPK11GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1396491-A2 2-substituted 4,5-diaryl-imidazoles and their use as p38 MAP kinase inhibitors Novartis AG (CH) 2004-03-10 EP claimed
EP-0993456-A1 2-SUBSTITUTED 4,5-DIARYL IMIDAZOLES Novartis AG (CH) 2000-04-19 EP claimed
WO-1999001449-A1 2-SUBSTITUTED 4,5-DIARYL IMIDAZOLES NOVARTIS AG (CH) 1999-01-14 WO claimed